共 5 条
[1]
Increased glycolytic sub-strate protects against isxhenic diastolic dysfunction;31p-NMR studies in the isolated blood perfused rat heart. Cave AC,Ebtrli FR,Ngoys,et al. Circulation . 2003
[2]
Ischemic heart disease and left ventrjiculardysfumchion:the role of trimetazidine. Belardinelli R. Italian Heart Journal . 2004
[3]
The autianginal drug trim-metazidine shifts cardial energy metabolism from fatly aeidoxidation to glucose oxidation by inhibiting mitochondriallong-chain 3-ketocyl coenzyme A thiloase. Kantor PF,Lucien,kozarr,et al. Circulation Research . 2000
[4]
Zong term cardioprotective action of trimetazidinl and potential ehect on the im-flammatory process in patients with ischaemic dilated car-diomy opatuy. Di Napoli P,Tacacrdi AA,Barsutti A. Heart . 2005
[5]
The hibernating myocardium:implacations formanagement of congstive heart failure. Bouow RO. The American Journal of Cardiology . 2005